水凝粘合剂用于上部胃肠道的伤口愈合
Lianjun Ma1, Fangming Gu1,2, Jiaqian Hu1,2
1China-Japan Union Hospital of Jilin University, Jilin University, Changchun 130033, P. R. China.
Theranostics
|December 22, 2025
概括
水凝粘合剂对上部胃肠道伤口的愈合有希望. 这些先进的材料在消化道的具有挑战性的酸性环境中提供有效的血液静止和修复.
科学领域:
- 生物材料科学 生物材料科学
- 胃肠病学 胃肠病学
- 再生医学是一种再生医学.
背景情况:
- 上部胃肠道的酸性环境对伤口愈合构成重大挑战,特别是对于胃出血和穿孔等疾病.
- 具有独特的3D网络结构的水凝由于其生物相容性和静血性质,已成为伤口带的有前途的生物材料.
研究的目的:
- 本综述总结了水凝粘合剂的最新进展,用于治疗各种上部胃肠道 (GI) 疾病.
- 它旨在全面了解GI伤口愈合中的水凝机制,益处和局限性.
主要方法:
- 关于用于上部胃肠道伤口愈合的水凝粘合剂的最新研究的文献综述.
- 分析与上部GI环境相关的水凝特性,包括生物相容性,生物降解性,机械强度和粘附性.
- 对食道狭窄,胃,出血,穿孔和内镜后的下切割进行水凝应用的评估.
主要成果:
- 水凝为消化道伤口提供高效的血液静止和修复策略.
- 生物相容性,生物降解性,机械强度和可控制释放等关键特性使得水凝适合复杂的伤口愈合.
- 目前的水凝敷料在一系列上部胃肠道疾病中表现出潜力.
结论:
- 水凝粘合剂在管理上部胃肠道伤口方面取得了重大进展.
- 鼓励对多功能水凝进行进一步的研究,以克服现有的挑战并提高治疗结果.
- 这篇综述强调了水凝有可能彻底改变上部胃肠道伤口治疗的潜力.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Peptic Ulcer Disease IV: Management
807
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807


